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and Small Molecules 
 
Jian Xiong 
Dr. Renee D. JiJi, Dissertation Supervisor 
 
ABSTRACT 
The amyloid-β (Aβ) peptide, a major component of the insoluble plaques associated with 
Alzheimer’s disease (AD), is the cleavage product of the transmembrane (TM) amyloid precursor 
protein (APP) and is known to possess an amiphiphilic nature. The full length A is intrinsically 
disordered under physiological conditions, but could aggregate over time to form soluble 
neurotoxic oligomers and eventually insoluble fibrils. Although great research interest has been 
drawn to the underlying mechanism of the development of AD, controversy remains and there is 
still a lack of established medical treatment.  
Previous studies have shown that A(25-40), the hydrophobic and TM fragment of A, 
behaves similarly to the full length A. The naturally occurring polyphenolic compound, 
myricetin, has been proven to inhibit the aggregation progress of A(25-40) in vivo. To better 
understand the aggregation propensity  of A itself and the interaction mechanism between A 
and myricetin, two site mutants, A(25-40) G37A and I32A, have been designed to interrupt the 
peptide backbone hydrogen bonding as well as reduce hydrophobic interactions. Further 
thioflavin T (ThT) assays and circular dichroism (CD) results indicate that the hydrophobic 
interactions may be crucial in Aβ(25-40)’s intrinsic aggregation propensity and also play an 
important role in the interaction between myricetin and Aβ.  Deep ultraviolet resonance Raman 
xii 
 
(dUVRR) and size exclusion chromatography (SEC) experiments suggest that the various initial 
oligomeric states may contribute to the altered Aβ(25-40) property.  
Derived from the membrane anchoring C-terminus of APP, Aβ is known to 
spontaneously associate with different types of lipid bilayers. To better understand the role of 
peptide-membrane interactions in AD, knowledge about how membrane characteristics affect 
binding, solvation, and secondary structure of Aβ is in demand. Employing a combination of CD 
and dUVRR spectroscopies, A(25-40) was found to spontaneously associate with anionic lipid 
bilayers and the structure of the membrane associated A(25-40) was dependant on both the 
hydrophobic thickness of the bilayer and duration of incubation. Further studies regarding the full 
length peptide indicate similarity between A(25-40) and A(1-40). After spontaneously 
associating with the negatively charged lipid bilayer, the full length A(1-40) initially adopts a 
mixed conformation of α-helical and disordered structures. The mixed structures then convert to 
more -sheet structure over longer time-frames, compared to the initial stage. -Sheet structure 
appears prior to the unwinding of the α-helix, implying a process in which -sheet structure, 
formed initially from disordered regions, destabilizes membrane solvated helical structure and 
then leads to the escape of peptide from the membrane surfaces.  
The generation of A involves a γ-secretase cleavage process within the membrane 
environment. However, there is no thorough understanding of how γ-secretase locates A and 
what structural changes are associated with this event. In fact, there is very limited knowledge 
about the structure of TM proteins, compared to their well studied soluble counterparts. Although 
TM proteins not only participate in disease development but also perform fundamental biological 
functions in human physiology, the application of traditional high resolution structural analysis 
strategies to TM proteins is quite limited due to their relatively large sizes, complex structural 
conformation, and the surrounding native lipid environment. Vibrational spectroscopy 
xiii 
 
methodologies, like dUVRR spectroscopy, offer an alternative approach to reveal the lipid 
solvated protein secondary structures as well as to monitor TM protein dynamics.  
Previous studies have produced a series of TM helical peptides to monitor the association 
and structure conformatioal equilibration between the membrane and peptides. In order to better 
define dUVRR characteristics of membrane associated/solvated protein secondary structure and 
establish potential quantitative relationships between the spectral response and the size of the 
protein TM domain, a series of model peptides, poly-(LA)x, were designed based on known TM 
helical peptides. It is found that both the length of the TM region of the peptide and the 
hydrophobic thicknesses determined by the lipid bilayer play important roles in the conformation 
of the final adopted structure, while the overall peptide secondary structures are predictable based 
on the TM region/hydrophobic thicknesses ratio and lipid bilayer composition.  
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CHAPTER I 
Introduction  
 
 
Background of Alzheimer's disease 
Alzheimer’s disease (AD), named after the German physician Alois Alzheimer, is 
now the most common progressive neurodegenerative disease.
1,2
 AD involves neuron 
damage or protein deposition in specific brain regions and will cause clinical symptoms 
including apraxia (loss of coordination), agnosia (impaired recognition) and aphasia (loss 
of language skills, difficulty speaking and writing).
3
 An estimated 5.4 million Americans 
of all ages had Alzheimer’s disease in 2011,4 and the population of AD patients could 
reach more than 81 million by 2040 all over the world.
1
 Cognitive tests, physical and 
neurologic examinations and magnetic resonance imaging (MRI) scans are popular 
diagnosis methods of the disease.
4
 The usage of Aβ production inhibitors, small anti-
oligomerization molecules, anti-inflammatory drugs and neuron-protection drugs, are 
current popular treatments for AD.
2
  
Alzheimer’s disease was first identified more than 100 years ago, but the cause(s) 
remains unclear. However, amyloid plaques are considered to be one of the pathological 
hallmarks of AD
5
. The amyloid-β (Aβ) peptide is the major component of the insoluble 
plaques associated with AD and typically has a length of 39-43 amino acids with the 
following sequence: 
Asp
1
-Ala
2
-Glu
3
-Phe
4
-Arg
5
-His
6
-Asp
7
-Ser
8
-Gly
9
-Tyr
10
-Glu
11
-Val
12
-His
13
-His
14
-Gln
15
-
Lys
16
-Leu
17
-Val
18
-Phe
19
-Phe
20
-Ala
21
-Glu
22
-Asp
23
-Val
24
-Gly
25
-Ser
26
-Asn
27
-Lys
28
-Gly
29
-
Ala
30
-Ile
31
-Ile
32
-Gly
33
-Leu
34
-Met
35
-Val
36
-Gly
37
-Gly
38
-Val
39
-Val
40
-Ile
41
-Ala
42
-Thr
43
. 
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Aβ is a normal and soluble component of human plasma and cerebrospinal fluid 
at sub-nanomolar concentration
6
 and it is a β- and γ- secretase cleavage product of the 
transmembrane amyloid precursor protein (APP).
7
 β-Secretase initializes the cleavage of 
APP at the N-terminus of the Aβ domain, followed by γ-secretase dependent cleavage 
deep within the membrane at the C-terminus of Aβ, which releases the peptide(Figure 
I.1).
8
 Derived from the transmembrane (TM) helix of the APP, Aβ is known to be 
disordered under physiological conditions.  
Previous studies suggest a number of various Aβ aggregation mechanisms and 
pathways, including the formation of Aβ oligomers, protofibrils, protofilaments, and 
fibrils.
9-13
 Pathology studies indicate that both the soluble and insoluble Aβ aggregates 
contribute to the neurotoxicity of Aβ, although the concentration of the peptide in the 
cerebrospinal fluid samples of patients is low.
14
 It is believed that preventing Aβ 
aggregation is a promising approach to treat AD; thus, it draws great attention to 
investigate both natural and synthetic aggregation inhibitors. 
 
Inhibitors of Aβ aggregation and their potential mechanism 
 Polyphenols and flavonoids are naturally abundant in a large variety of plants, 
some of which are edible, like green tea.
15
 These categories of compounds have 
beneficial effects to human health, such as anti-bacterial, anti-inflammatory and anti-
allergic activities.
16,17
 Previous studies have identified a number of naturally occurring 
anti-amyloidogenic small molecules using electron microscopy (EM) and thioflavin T 
(ThT) fluorescence assays, and the aggregation inhibitors were proposed to be 
categorized into three classes: (I) compounds that inhibit oligomer formation but do not 
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prevent fibrillogenesis, (II) compounds that inhibit fibrillization but do not interfere with 
oligomerization, and (III) compounds that inhibit both oligomerization and fibril 
formation.
18
 A number of polyphenolic compounds, including some flavonoids, have 
been shown to inhibit amyloid fibril formation in vitro and in vivo, such as myricetin and 
quercetin.
19-21
 Myricetin dose-dependently inhibited Aβ fibril formation and extension, as 
well as destabilized the fibrillar form of Aβ.22 Myricetin was also suggested to block the 
addition of Aβ monomers to the growing end of the Aβ aggregates and  result in 
elimination of large aggregate and mature fibril structures.
23
 Hydrophobic interactions 
and hydrogen bonding with positively charged amino acid side chains
24-26
 may be the 
potential driving forces of interaction between Aβ and myricetin. The heteroaromatic 
interactions between the aromatic residues of the peptide and phenolic compounds have 
been suggested to induce binding as well.
27,28
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Figure I.1 Cleavage of APP leads to the formation of A peptide. 
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Aβ interacts with membrane and the potential mechanism 
Being cleaved from the membrane anchoring C-terminal region of the parent 
APP, roughly one third of the A peptide has a high degree of insolubility in aqueous 
environment.
29
 Previous studies have shown that the A interacts with and aggregates at 
membrane surfaces presumably because of its amphiphilic nature.
30-36
 Specifically, both 
the full length A(1-40) and A(25-35) are reported to interact with anionic lipid 
membrane due to electrostatic interactions.
37
 However, a controversial conclusion has 
been drawn from studies that indicate that A(25-35) inserts into neutral lipid bilayers is 
due to its hydrophobicity, during which the presence of cholesterol may vary the extent 
of the insertion of  A.38,39 Previous studies also indicate that the potential neurotoxicity 
of A can be attributed to the pore-like structures formed after the interaction between 
A and the membrane, leading to an imbalanced calcium levels across the membrane and 
eventually to cell death
40
. Some studies show that full length A(1-40) will fold into an 
-helical structure in the presence of SDS micelles above the critical micelle 
concentration (CMC),
41
 and the localized helix will be formed by residues 15-24 and 29-
35 with a kink at residues 25-28.
42,43
 Other studies indicate the potential of ion channels 
or a -sheet structured pore in lipid membranes.44-46 Yet, with the increasing research 
interest regarding the interactions between A and membranes, there is still a lack of a 
detailed mechanism for how A is attracted to the membrane surface and disrupts he 
membrane. After binding to the lipid bilayer, A may adopt a different structure which 
contributes to the complexity of the interaction. It is currently known that disordered A 
binds to model membranes and forms -helical and -sheet structures depending on lipid 
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characteristics,
31
 whereas oligomers may bind model membranes and form  pore-like 
structures.
46
 
 
Spectroscopic methodologies  
Circular dichroism (CD)  
Circular dichroism (CD) is a spectroscopic method that measures the difference in 
absorption of circularly (left and right) polarized light by an analyte. Typically, CD will 
occur when an analyte is (a) intrinsically chiral, (b) linked to a chiral center, or (c) placed 
in an asymmetric environment. Because it is a particularly powerful tool for monitoring 
conformational changes, CD is widely applied to the study of protein structure (Figure I. 
2). A lot of useful information about a protein can be gained through CD.  The bonds of 
the peptide backbone absorb in the 190-250 nm range, giving us information about 
secondary structure; each type of secondary structure has a signature spectral shape. The 
α-helix is characterized by two negative features at 208 and 222 nm and one positive 
feature at 193 nm (Figure I. 2 red). The β-sheet has a distinct positive feature around 194 
nm and a negative feature around 217 nm (Figure I. 2 blue). The poly-proline II (PPII) 
structure is characterized by a negative feature at 196 nm and a broad positive feature at 
210-217 nm (Figure I. 2 black). Environmental information about the side chains, 
especially aromatic ones, can be found in the 260 nm to 320 nm region if demanded.  
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Figure I. 2. CD of protein secondary structure, demonstrated for ovalbumin (inset 
structure): α-helix in red, β-sheet in blue and PPII in black. 
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Deep UV Resonance Raman (dUVRR) spectroscopy  
Raman spectroscopy is named after its discoverer Sir Chandrasekhara Venkata 
Raman. It is a type of vibrational spectroscopy which measures the difference in 
wavelengths between incident and scattered light. Raman spectroscopy was found to be 
sensitive to the chemical structures of the molecules responsible for the scattering.
47
 In 
resonance Raman spectroscopy, the sample will be excited by a laser source to an excited 
electronic state, which enhances the intensities of the spectra by a factor of 10
2
 to 10
6
, 
compared to ordinary Raman spectroscopy. 
There are mainly four amide regions related to protein secondary structure: the 
amide I (1600 to 1700 cm
-1
) is predominantly a carbonyl stretching. The amide II (1500 
to 1600 cm
-1
) is an combination of C-N stretching and N-H in-plane bending. The amide 
III (1200 to 1350 cm
-1
) is also derived from C-N stretching and N-H bending, but it is 
more sensitive to protein secondary structure, according to previous literatures. The 
amide S mode, alternatively called the CαH bending mode,48 usually appears from 1374-
1397 cm
-1
 for disordered structures and 1395-1406 cm
-1
 for beta sheet structures. The 
Raman spectra of fully α-helical peptides contain no amide S mode due to the lack of 
coupling between the Cα hydrogen and the amide hydrogen.49 Besides all the amide 
modes derived from the protein backbone, aromatic side chains on the amino acids 
provide distinctive features as well. Figure I. 3 demonstrates a typical dUVRR spectrum 
of a protein which lacks aromatic amino acids. 
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Figure I. 3. DUVRR spectra of Aβ(25-40) in phosphate buffer. Four amide modes 
are dominant features in the spectrum and no aromatic feature is present. 
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Chapter II 
Pursuing the Driving Force of Aβ Aggregation Using Various 
Spectroscopic Methods 
 
ABSTRACT 
The amyloid-β (Aβ) peptide, a major component of the insoluble plaques 
associated with Alzheimer’s disease, is intrinsically disordered under physiological 
conditions. Many polyphenolic compounds disrupt aggregation of Aβ in vitro, though the 
exact mechanism remains unclear. Circular dichroism (CD) and deep ultraviolet 
resonance Raman (dUVRR) studies of Aβ(25-40) and its site mutants G37A and I32A 
suggest that a polyphenolic flavonoid, myricetin, interacts with the peptide through 
hydrophobic interactions although these interactions may take place at late stages in the 
presence of a mixture of Aβ(25-40) oligomers. Moreover, spectroscopic studies of I32A 
indicate that hydrophobic interactions play an important role in Aβ(25-40)’s intrinsic 
tendency towards aggregation. DUVRR suggests that both G37A and I32A mutation may 
lead to various levels of peptide backbone desolvation among different oligomeric 
species although there is no detectable secondary structure differences. Further, size 
exclusion chromatography confirms the existence of a series of oligomeric species 
initially and the distributions of the oligomers may play important roles in the 
aggregation process. 
. 
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INTRODUCTION 
Alzheimer’s disease (AD), named after the German physician Alois Alzheimer, is 
now the most common form of dementia in the US.
50
 AD involves neuronal damage and 
protein deposition in extracellular (plaques) and intraneuronal (neurofibrillary tangles) 
regions of the brain. Extracellular plaques are composed predominantly of the -amyloid 
(A) peptide, whereas the hyperphosphorylated tau protein makes up neurofibrillary 
tangles.
51
 Clinical symptoms include apraxia (loss of coordination), agnosia (impaired 
recognition) and aphasia (loss of language skills, difficulty speaking and writing).
52
 In 
2011, an estimated 5.4 million Americans had AD and the worldwide population of AD 
patients could reach more than 81 million by 2040.
1
  
AD was first identified more than 100 years ago, but the cause or causes is still 
under debate.
2
 However, insoluble plaques are considered to be one of the pathological 
hallmarks of AD. The aggregation mechanism of Aβ is complex and could involve 
multiple pathways.
53,54
 The diffusion-limited aggregation (DLA) model was proposed in 
1992 to explain Aβ aggregation. According to the DLA model, Aβ monomer seeds 
spontaneously convert to octamers, which stack to form protofibrils. Protoibrils are then 
proposed to elongate by diffusion limited end-to-end association and eventually form 
fibrils.
55
 The DLA model was modified in 2001 to include formation of a multimeric 
nucleus, from which filaments elongate and aggregate to form fibrils that grow though 
end-to-end association.
56
 While the presence of plaques has been considered a hallmark 
of AD, high concentrations of soluble A tend to correlate more with the presence of 
clinical AD symptoms.
14
 
Potential treatments for AD include Aβ production inhibitors, small anti-
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oligomerization molecules, anti-inflammatory drugs and neuron-protection drugs.
2
 
However, interest in the therapeutic use of naturally occurring polyphenolic compounds 
for neurodegenerative diseases is also increasing.
57-59
 Polyphenols and flavonoids are 
naturally abundant in a large variety of edible plants
15
 and have beneficial effects 
including anti-oxidant, anti-bacterial and anti-inflammatory activities.
16,17
 Additionally, a 
number of polyphenolic compounds, including some flavonoids, have been shown to 
have anti-amyloidogenic activity.
21,60,61
 Polyphenols have been shown to interact 
with/bind to proteins through hetero-aromatic interactions, hydrophobic interactions and 
hydrogen bonding with the backbone or positively charged amino acid side chains,
28,62
 
which could be related to their anti-amyloidogenic activity. 
Previous studies have shown that the aggregation propensity of full length Aβ(1-
40) is similar to its hydrophobic fragment Aβ(25-40) and the flavonoid myricetin fully 
inhibits fibrillization of both peptides.
63
 While there is evidence of aromatic interactions 
between full length Aβ and myricetin,28 the mechanism of interaction between myricetin 
and the hydrophobic fragment Aβ(25-40) is not known. Two site mutations were made to 
examine the effects of diminished hydrophobic interactions and backbone hydrogen 
bonding on myricetin’s anti-amyloidogenic activity. It has been suggested that sequential 
glycines allow the polyphenol to hydrogen bond with the peptide backbone.
64
 To prevent 
the phenol groups from hydrogen bonding with the peptide backbone, glycine 37 was 
changed to alanine (G37A). Similarly, sequential isoleucines are present at position 31 
and 32. Isoleucine 32 was changed to alanine to slightly reduce the hydrophobicity of the 
peptide, and interfere with hydrophobic interactions (I32A).
65
 Mutation of these residues 
should conserve the amyloidogenic properties of Aβ(25-40),66 while potentially reducing 
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the binding affinity of myricetin. While the effects of these mutations should be 
moderate, dramatic differences were observed in their oligomer distributions and rates of 
aggregation. 
 
EXPERIMENTAL PROCEDURES 
Aβ(25-40) and the two site mutants, G37A and I32A, were synthesized by Dr. 
Fabio Gallazzi in the Structural Biology Core Facility, University of Missouri-Columbia. 
Each peptide was purified using an analytical Beckman System Gold HPLC system 
(Beckman Coulter, Brea, CA) fitted with a C18 column (Grace Vydac Protein & Peptide, 
Southborough, MA). Ultra pure water (18 M) was obtained using a Barnstead Diamond 
system (Barnstead International, Dubuque, IA). The pH of the water was adjusted to 2.5 
using concentrated HCl (Fisher Scientific, Pittsburgh, PA) to optimize purification. Water 
and acetonitrile (Fisher Scientific, Pittsburgh, PA) were applied as an eluent system. 
Sodium phosphate monobasic, sodium phosphate dibasic, sodium chloride (Fisher 
Scientific, Pittsburgh, PA) and sodium perchlorate (Sigma-Aldrich, St. Louis, MO) were 
used to prepare buffers. Thioflavin T (ThT), purchased from Sigma-Aldrich (St. Louis, 
MO), was dissolved in ethanol and diluted to a 150 μM stock solution with 10 mM 
phosphate buffer.  
Aβ(25-40) (M.W. 1470) and two single site mutants G37A (M.W. 1484) and 
I32A (M.W. 1428), were directly dissolved in 10 mM pH 7.4 sodium phosphate buffer 
and sonicated in an ice bath for two minutes to break up aggregates. Subsequently the 
solution was centrifuged for 30 minutes at 14000 rcf at 4 °C to remove insoluble 
aggregates and the supernatant was collected for future use. The concentration of each 
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solution was estimated using a molar extinction coefficient of 17385 L mol
-1
 cm
-1
, 
determined from the side chain and peptide bond extinction coefficients at 215 nm.
67,68
 
All solutions were adjusted to a final concentration of 50 μM. A 20 mM stock myricetin 
(MP Biomedicals, Solon, OH) solution was made by dissolving myricetin in ethanol. A 
small aliquot of the stock solution was then added to the peptide solution for a final 
myricetin concentration of 25 μM. 
 
Thioflavin T (ThT) Fluorescence Assay. 
Sample solutions of each peptide were prepared as stated above and were 
incubated at 37 °C for 11 days. During the incubation period, 70 μL of each sample was 
collected on days 0, 1, 2, 3, 5, 7 and 11. A small amount of the 150 μM ThT stock 
solution was added to each sample for a final ThT concentration of 5 μM. Fluorescence 
spectra were collected using a Cary Eclipse fluorescence spectrometer (Varian, Palo Alto, 
CA), using a 3 mm path length quartz cell (Hellma USA, Plainview, NY). Spectra of 
each sample were measured using an excitation wavelength of 450 nm with a slit width 
of 5 nm. The emission spectrum was collected between 470 and 700 nm with a slit width 
of 5 nm. Data points from 478 nm to 482 nm were averaged for a mean intensity at 480 
nm, which is used in Figure II. 1. 
 
 Size Exclusion Chromatography (SEC). 
A BioLogic DuoFlow FPLC chromatography system (Bio-Rad, Hercules, CA) 
fitted with a Superdex 75 10/300 GL column (GE Healthcare, Uppsala, Sweden) was 
employed for the SEC. The system was pre-equilibrated with 50 mM phosphate buffer 
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with 150 mM NaCl and  the same buffer was used as eluent. Peptide samples were made 
as described earlier and an injection volume of 250 μL was used. The SEC was 
performed at 4 °C at a flow rate of 0.5 mL/min and monitored by UV absorption at 
215 nm by a Quad-Tec detector (Bio-Rad, Hercules, CA). A molecular weight ladder 
consisting of BSA, ovalbumin, ribonuclease A and vitamin B12 was applied to construct a 
linear regression of the log of the molecular weight vs. the Kav, where 
                      Kav=Vr-V0/Vm-V0                                            (1) 
Vr is the elution volume of the sample. Void volume, V0, was calculated by 
running an extremely high molecular weight sample of blue dextran at 1 mg/mL while 
column volume, Vm, is determined to be 24 mL according to the manufacture's manual. 
Chromatograms of peptides were fit with mixed Gaussian and Lorentzian (5% max) 
bands to determine retention times. Peak areas were then calculated in the Matlab (Math-
Works, Natick, MA) environment to compare the initial and final state of the composition 
of different oligomeric species.   
 
Circular Dichroism Spectroscopy.  
An AVIV 62DS circular dichroism (Aviv Biomedical Inc., Lakewood, NJ) 
spectrometer and a quartz cell with a 1 mm optical path length (Hellma USA, Plainview, 
NY) were used to collect CD spectra. All spectra were collected between 190-250 nm 
with a resolution of 0.1 nm under room temperature. Every sample was measured 5 times 
with a scan speed of 1 nm/5 s. Corresponding background spectra were collected in the 
same manner and subtracted from the sample data, and then the mean residue molar 
ellipticity [θMRE] was calculated.  
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Deep Ultraviolet Resonance Raman Spectroscopy. 
All dUVRR spectra were collected on a custom built system and similar UVRR 
systems have been described previously.
63
 Briefly, a Nd:YLF pumped Ti:sapphire laser 
system (Coherent, Santa Clara, CA)  is used to generate a 197 nm excitation beam. The 
beam is attenuated to an average power of approximately 0.5 mW to minimize sample 
degradation during the UVRR data collection. A custom sample reservoir (Mid Rivers 
Glassblowing, St. Charles, MO) was used to hold the sample under a steady nitrogen gas 
flow and a miniplus2 pump (Gilson Medical Electronics, Middleton, WI) was applied to 
circulate the sample from the reservoir through two parallel nitinol wires (Small Parts, 
Inc., Miramar, FL) to form a very thin film. The Raman signal was collected using a 
Symphony CCD camera (Horiba Jobin Yvon Inc., Edison, NJ) with a chip size of 2048 × 
512 pixels. A bin of 4 in the horizontal direction gave a final resolution of 2.4 cm
-1
. 
Spectra were collected and exported using Synergy software (Horiba Jobin Yvon Inc., 
Edison, NJ). Spectra were calibrated using a standard cyclohexane spectrum. Each 
sample contained 50 mM sodium perchlorate (ClO4
-
, 932 cm
-1
), which was used as an 
internal intensity standard. Five 60 s scans with 72 replicates, 6 hours total, were 
averaged for each spectrum. The data were processed using Matlab. Individual spectra 
were fit with a mixture of Gaussian and Lorentzan bands to determine peak positions.  
 
RESULTS  
 Peptide backbone hydrophobicity plays an important role in the aggregation 
propensity of  Aβ(25-40). 
Previous work has shown that Aβ(25-40) maintains similar behavior to the full 
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length Aβ(1-40) during the aggregation process.63 G37A is designed to interrupt the 
hydrogen bonding between the peptide backbone, while the hydrophobic interaction was 
reduced by I32A. In order to characterize the aggregation propensity of Aβ(25-40) and its 
mutants, a series of ThT assays was performed to monitor the appearance of amyloid 
structures.
69,70
 With the methods described earlier, fresh samples of Aβ(25-40) and its 
mutants were prepared and a data collection period of 11 days was applied and the results 
are shown in Figure II. 1. The increasing fluorescence intensity at 480 nm indicates that 
all of the three samples formed fibril or cross β-sheet structures during the incubation 
periods. The figure indicates that after 5 days of incubation at 37 °C, Aβ(25-40) and 
G37A reach the peak intensity and stay for 2 days then begin to decrease. However, 
although Aβ(25-40) and G37A show slightly different fluorescence intensities, there is no 
significant statistical difference between these two, when taking their error levels into 
consideration. ThT assays also indicate that the I32A peptide does not aggregate as 
readily as Aβ(25-40) or the G37A peptide. It took 2 more days for I32A to reach the 
intensity maximum, and the maximum was approximately 2 fold lower than its siblings, 
suggesting that the hydrophobicity of the peptide backbone plays a role in the 
aggregation propensity.  
However, Aβ(25-40), G37A and I32A show no obvious fluorescence increase at 
480 nm when treated with 25 μM myricetin as aggregation inhibitor over the same period 
of time (figure not shown). Previous studies have shown hydrophobic interactions and/or 
hydrogen bonds to positively charged amino acid side chains could induce interactions 
between Aβ and myricetin towards aggregation inhibition. The fact that myricetin inhibits 
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the minor aggregation of I32A indicates that the hydrophobic interaction may not be the 
only potential mechanism of Aβ-myricetin interaction at the early stage.  
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Figure II.1. ThT assay for amyloid formation of Aβ(25-40) (black), G37A (dark 
grey) and I32A (light grey) at pH 7.4 in 10 mM phosphate buffer, incubated at 37 °C for 
12 days. Results based on three replicates and the fitted lines are for visual guidance only. 
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Backbone hydrophobicity plays an important role in the aggregation of Aβ(25-
40).   
A set of CD spectra (Figure II. 2) of the fresh peptide samples also indicates that 
there is some difference among the original secondary structures of the peptide, which 
may account for the difference shown by the ThT assay.  
To begin with, the CD results indicate that all three peptides showed clearly PPII 
structures, indicated by the strong negative feature at approximately 197 nm (Figure II. 2 
A). Specifically, the negative magnitude for the G37A and I32A mutants at the trough of 
197 nm, which is an important indicator of the content of PPII structures, appears similar, 
but it is significantly lower in the Aβ(25-40) peptide. The difference can be attributed to a 
higher PPII structure content in the mutants, and it is also an indication that backbone 
hydrogen bonding and hydrophobicity could alter the initial conformation of Aβ(25-40) 
in aqueous buffer. In addition, a small negative feature around 220 nm can be observed in 
all three peptides, which strongly suggests the existence of a low content β-sheet/strand 
structure. 
Secondly, the CD spectra with and without myricetin (Figure II. 2 B and C) 
indicate that the intensities of the trough at 197 nm are slightly different for both Aβ(25-
40) and G37A, due to possible myricetin binding. However, myricetin did not alter the 
CD spectra of the I32A mutant in a similar manner (Figure II. 2 D): no obvious 
difference is shown in the spectra of I32A with or without myricetin, suggesting 
hydrophobic interactions may be important for myricetin-Aβ binding, while hydrogen 
bonding may not lead to a visible secondary structure change detectable by CD. 
Combined with the ThT assay results, it is rational to claim that hydrogen bonding 
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contributes to the myricetin-Aβ interaction initially, while hydrophobic interactions may 
take place during fibril formation at a later stage. 
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Figure II.2. CD of fresh Aβ(25-40) (black), G37A (dark grey) and I32A (light 
grey) at pH 7.4 in 10 mM phosphate buffer (A) and individual peptide with myricetin (B, 
C, and D). Error bars in B, C, and D based on three replicates. 
 
 
 
 
 
 
  
 
23 
 
DUVRR spectra indicate different extents of solvation. 
DUVRR is sensitive to protein secondary structure and has been applied in 
previous research. Briefly, there are four amide regions containing detailed protein 
secondary structure information: amide I (1600-1690 cm
-1
) mode is mainly derived from 
C=O stretching; amide II mode (1450-1580 cm
-1
) is caused by C=N stretching and N-H 
bending; amide S mode (1300-1425 cm
-1
) can be assigned to the coupled N-H and Cα-H 
bending and III (1200-1300 cm
-1
) is generally the combination of C=N stretching and Cα-
H bending modes. In Figure II. 3, the amide I and amide II bands of Aβ(25-40) could be 
fit with two single peaks centered at 1656 cm
-1
 and 1556 cm
-1
, respectively. The amide 
III region could be deconvoluted into two peaks, which locate at 1249 and 1300 cm
-1
. 
The amide S band contained a single component at 1388 cm
-1
. Similarly, G37A mutation 
needed one band to fit the amide I region at 1665 cm
-1
, and one band centered at 1561 
cm
-1
 is sufficient to fit the amide II band. The amide III band region could be fit with two 
components at 1250 and 1300 cm
-1
. The amide S band had one component at 1388 cm
-1
. 
The amide I and II regions of I32A mutation could be fit with two single peaks at 1679 
and 1565 cm
-1
. The amide III band region could be deconvoluted with two components at 
1248 and 1295 cm
-1
. The fitted amide S band had one component centered at 1388 cm
-1
.  
The similarity of the amide III and S regions in the dUVRR spectra of the three 
peptides indicates that all the peptides adopt a disordered structure, which is consistent 
with the CD results. However, there are two types of disordered structure: PPII and β-
strand. The dUVRR shows a slight difference in the I32A spectrum: two components at 
1248 and 1295 cm
-1
 indicate the initial secondary structure of I32A could have a higher 
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PPII structural content, indicating the I32A may exhibit a different initial state than 
Aβ(25-40) and G37A.  
Compared to the similar amide III and S regions, the amide I region of the three 
peptides shows significant differences. Previous studies indicate that the hydration extent 
can affect the position and intensity of the amide I region. The intensity of the amide I 
region will increase when the backbone of a peptide is less hydrated, due to the lack of 
hydrogen bonding to the aqueous environment. The intensity of the amide I region of 
G37A is significantly lower than that of Aβ(25-40), while the I32A has the lowest among 
the three. Considering the slightly shifted amide III region, these results suggest that the 
initial structure of I32A contains both higher PPII content and is more exposed to solvent.    
With the presence of 25 μM myricetin, the dUVRR spectra of all three peptides 
show no obvious differences (Figure II. 4), especially in the amide I and II regions. These 
results demonstrate that although CD indicates a slightly different secondary structure, 
the mycetin-Aβ interaction does not contribute to detectable changes by UVRR. Unlike 
the previous UVRR study,
63
 potential aromatic interaction is eliminated given the fact 
that there are no aromatic amino acid residues in Aβ(25-40). 
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Figure II.3. DUVRR of Aβ(25-40) (black), G37A (dark grey) and I32A (light 
grey).  
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Figure II.4. DUVRR amide I and II region of Aβ(25-40) (black), G37A (dark 
grey) and I32A (light grey) with (dotted line) and without (solid line) myricetin. 
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SEC suggests that the initial oligomeric state varies upon mutation. 
SEC is carried out in order to demonstrate the variation of the initial oligomeric 
state of the three peptides in solution. The SEC indicates that the initial state of Aβ(25-
40) contains three major species of aggregates, including monomer, trimer and tetramer 
(Figure II. 5). According to the fit peak area, each species represents 2%, 20% and 77% 
of the total area, respectively. After 48 hour of incubation at 37 °C, the peptide contains 
9%, 37% and 54% of monomer, trimer and tetramer, respectively with an overall drop in 
signal intensity (Table II.1). Based on the relationship of molecular weight and elution 
volume, potential octamer should maintain a retention time around 29.5 min, which is not 
observed. These results indicate that the Aβ(25-40) forms higher ordered insoluble 
oligomers that cause the general peak intensity to drop and the tetramer may be the 
critical species to form larger aggregates.  
The corresponding SEC results of Aβ(25-40) with myricetin have a different 
pattern, indicating that the presence of the inhibitor affects the initial oligomeric 
distribution. The percentage of the tetramer decreases to 47% and the trimer is 36%. The 
fit peaks also indicate that there is approximately 6% dimer and 10% monomer, 
suggesting that the myricetin may increase the distribution of lower oligomeric state 
species. After 48 hours, the general shape of the chromatogram is similar to the initial, 
with the fact that tetramer and trimer contribute 56% and 37% of the total area, 
respectively.  
The chromatogram of G37A indicates a different pattern from the wild type 
peptide Aβ(25-40) at the initial state. Dimer and trimer contributes 64% and 32% of the 
total area, respectively, and the rest can be assigned to monomer and two higher order 
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aggregates. The lack of tetramer may cause the less pronounced ThT fluorescence. With 
the 48 hour incubation period, the dimer and trimer contribute 77% and 20% of the total 
area, respectively.  
  The initial size distribution of I32A also shows a dramatic difference. There is 
46% of the dimer and 41% of the trimer present in the initial state, which ranks the 
highest among the three peptides. After 48 hours of incubation at 37 °C, the dimer and 
trimer take 51% and 40%, respectively. These results indicate that decreased peptide 
backbone hydrophobicity may lead to a high percentage of trimer oligomer, which could 
not form  cross β-sheet/fibril as readily as the tetramer. 
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Figure II.5. SEC results of initial (hour 0, solid lines) Aβ(25-40) (black) and 
Aβ(25-40) with myricetin (grey), G37A (red) and I32A (blue) and final (hour 48, all 
dashed lines) . 
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Table II.1 Summary of the SEC results.  
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DISCUSSION 
Aβ is known to have complicated aggregation pathways and to spontaneously 
form oligomers in solution. The ThT results of the peptides suggest some dramatically 
different aggregation tendencies of the peptides in aqueous environment. G37A behaves 
similarly to the wild type peptide with small changes in the aggregation rate while I32A 
indicates that the backbone hydrophobicity contributes crucially to the intrinsic driving 
force of aggregation. Moreover, the CD results suggest that both G37A and I32A contain 
more PPII structure than the wild type Aβ(25-40) and potential myricetin-Aβ interaction 
could be derived by backbone hydrogen bonding between the peptide and myricetin at an 
early stage. As the aggregation progresses, hydrophobic interactions may also take place 
between the peptide and myricetin, which will lead to the elimination of the fibril 
structure. DUVRR results indicates that although the overall secondary structures are 
similar in all three peptides, the oligomeric states of the samples may vary. Specifically, 
the oligomer of Aβ(25-40) is less water accessible than that of the G37A while I32A 
forms the most solvent-exposed oligomer among the three, leading to diminished 
aggregation. The SEC results confirm that the samples contain different species of 
oligomers with various percentages. It is rational to claim that dimer and tetramer may 
lead to steady aggregates while trimer may not form insoluble aggregates within the 
experimental period and the insoluble aggregates may affect the intensity of the 
chromatogram. The SEC also indicates that the presence of myricetin may cause 
disassociation of the higher order oligomer and thus interrupt the aggregation process. 
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CHAPTER III 
Role of Bilayer Characteristics on the Structural Fate of A(1-40) and 
A(25-40) 
 
ABSTRACT 
The -amyloid (A) peptide is derived from the transmembrane (TM) helix of the 
amyloid precursor protein (APP) and has been shown to interact with membrane surfaces. 
To understand the role of peptide-membrane interactions in cell death and ultimately 
Alzheimer’s disease, a better understanding of how membrane characteristics affect 
binding, solvation, and secondary structure of A is needed. Employing a combination of 
circular dichroism (CD) and deep UV resonance Raman (dUVRR) spectroscopies, 
A(25-40) was found to fold spontaneously upon association with anionic lipid bilayers. 
The hydrophobic portion of the disease-related A(1-40) peptide, A(25-40), has often 
been used as a model for how its legacy TM region may behave structurally in aqueous 
solvents and during membrane encounters. The structure of the membrane associated 
A(25-40) peptide was found to depend on both the hydrophobic thickness of the bilayer 
and the duration of incubation. Similarly, the disease-related peptide, A(1-40), also 
spontaneously associates with anionic liposomes where it initially adopts mixtures of 
disordered and helical structures. The partially disordered helical structures, then convert 
to -sheet structures over longer time-frames. -Sheet structure is formed prior to helical 
unwinding, implying a model in which -sheet structure, formed initially from disordered 
regions, prompts the unwinding and destabilization of membrane stabilized helical 
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structure. A model is proposed to describe the mechanism of escape of A(1-40) from the 
membrane surfaces following its formation by cleavage of APP within the membrane. 
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INTRODUCTION 
Alzheimer’s disease (AD) is manifested through loss of memory, disorientation 
and difficulty performing daily tasks. AD is a growing epidemic, affecting more than 25 
million people worldwide.
71
 A hallmark of AD is insoluble extracellular senile plaques, 
composed of a 39-42 residue peptide fragment termed amyloid- (A). A is generated 
during normal cleavage of the membrane anchored amyloid precursor protein (APP) by 
- and - secretases.72 Roughly one third of the A owes its high degree of insolubility to 
the fact that 12-14 of its residues derive from the membrane anchoring C-terminal region 
of the parent APP protein
29
. Studies have shown that A interacts with and aggregates at 
membrane surfaces presumably because of its amphiphilic nature.
30-36
 Yet, the 
mechanism of these membrane induced aggregation events is not well understood.  
Protein-lipid interactions are diverse and can cause dramatic structural changes in 
proteins, resulting in folding, unfolding or even misfolding. For example, human islet 
amyloid polypeptide (hIAPP or amylin), associated with type II diabetes, forms -sheet 
aggregates in the presence of anionic lipids.
73
 Conversely, the naturally occurring prion 
protein (PrPC), normally associated with cholesterol rich lipid rafts,
74
 may translocate to 
lipid domains with altered levels of cellular cholesterol and convert to the misfolded form 
(PrPSc).
75
 A is a complex peptide, demonstrating structural plasticity depending on 
preparation and incubation time. In aqueous solvents, A is disordered in its monomeric 
form
76
 and -sheet structured in its fibrillar form.77 A begins to form oligomeric 
structures within the first 24-48 hours of incubation at 37 °C.
35
 These oligomeric species 
come in many forms, including amlyloid derived diffusible ligands (ADDL’s),78 
protofibrils,
79
 annular protofibrils,
80
 and globulomers.
81
 Although the tertiary structures 
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of early oligomers, protofibrils, and globulomers are vastly different, they all have -
sheet secondary structure.
79, 81, 82
 However, studies of A(1-40) in SDS micelles indicate 
formation of stable -helical structure above the critical micelle concentration (CMC).41 
NMR studies have localized -helical structure of A(1-40) to residues 15-24 and 29-35 
with a kink at residues 25-28.
42,43
 Other studies indicate the potential of A to form ion 
channels or a -sheet structured pore in lipid membranes.44-46 A has also been shown to 
undergo -helical to -sheet conformational changes in the presence of low 
concentrations of fluorinated alcohols.
76
 Mounting evidence suggests that the increased 
neurotoxicity of A oligomers is derived from their interactions with neuronal 
membranes.
83
  
It is currently known that disordered A binds to model membranes and forms -
helical and -sheet structures depending on lipid characteristics,31 whereas oligomers 
may bind model membranes and form  pore-like structures.
46
 Although the instability of 
A's structure in membrane mimicking environments is known, a better understanding of 
how membrane characteristics affect the binding, solvation, and secondary structure of 
A is still needed.  
Deep UV resonance Raman (dUVRR) spectroscopy has been employed to study 
oligomerization and amyloid fibril formation in the aqueous environment.
84
 Furthermore, 
comparative dUVRR studies, using 197 nm excitation on predominantly -helical 
proteins show that transmembrane (TM) proteins have an unusually strong amide I 
band.
85, 86
 In fact, the amide I mode appears to be highly sensitive to solvent mediated 
hydrogen bonding, or lack thereof, consistent with its enhancement in lipid environments, 
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87, 88
 making it a logical tool for localization of the transient structure versus the 
membrane proper. Therefore, dUVRR analysis was utilized to understand better how 
lipid membranes and bilayer content affect the structures of A and how these ensemble 
structures change over time.  
 
EXPERIMENTAL PROCEDURES 
Crude Aβ(25-40) and Aβ(1-40)  peptides were synthesized by the Structural 
Biology Core Facility, University of Missouri-Columbia and were further purified using 
an analytical System Gold HPLC (Beckman Coulter, Brea, CA) fitted with a C18 column 
(Grace Vydac protein and peptide, Deerfield, IL). Acetonitrile (Fisher Scientific, 
Pittsburgh, PA) and water (pH 2.5) were employed to optimize separation. AcWL5 was 
purchased from Pi Proteomics (Huntsville, AL) and used without further purification.  
DMPC, DMPG, DLPG and DDPG lipid powder were obtained from Avanti Polar Lipids 
(Alabaster, AL). DMPG was dissolved in a mixture of chloroform (Fisher Scientific, 
Pittsburgh, PA)/methanol (Fisher Scientific, Pittsburgh, PA)/water (65:35:8, v/v/v). 
DMPC, DLPG, and DDPG were dissolved in extra dry chloroform (Acros Organics, 
Geel, Belgium). Lipid solutions were transferred into glass test tubes, dried under argon, 
and kept under vacuum overnight to remove any trace of solvent. Phosphate buffer was 
prepared using monobasic sodium phosphate, dibasic sodium phosphate, sodium chloride 
(Fisher Scientific, Pittsburgh, PA), and sodium perchlorate (Sigma, St Louis, MO). 
Sample preparation.  
Approximately 1.5 mg of purified Aβ(25-40) in 10 mM, sodium phosphate buffer, 
pH 7.4, was sonicated at 4 °C for two minutes to break up aggregates. Any remaining 
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insoluble aggregates were removed by centrifugation for 30 minutes at 14000 rcf at 4 °C. 
The concentration of the Aβ(25-40) solution was estimated using a molar extinction 
coefficient of 17385 M
-1
 cm
-1
, which was estimated from the side chain and peptide bond 
extinction coefficients at 215 nm.
63
 Aβ(1-40) was prepared similarly except that the 
concentration was determined using the tyrosine molar extinction coefficient of 1405 M
-1
 
cm
-1
 at 274 nm.  The concentration was adjusted to 50 μM for aqueous samples. The 
lipids were resuspended in 20 mM phosphate buffer, pH 7.4, with 5 mM NaCl and 
sonicated at 50 °C for one hour. The solution was then extruded with a 100 nm pore 
diameter polycarbonate membrane (Avestin Inc., Ottawa, Canada) to produce 
monodisperse liposomes. The concentration of the lipids was then estimated by a Rouser 
assay
89
 and the size distribution of the liposomes was determined using a DynaPro-
MSTC dynamic light scattering (DLS) instrument (Protein Solution Inc., Somerset, NJ). 
Lastly, the peptide solution was added to the concentrated liposome solution at a 1:100 
peptide:lipid ratio for a final concentration of 50 μM peptide and 5 mM lipid. The 
AcWL5 peptide was hydrated with 15 mM DMPC lipid and incubated at 37 C for at 
least 4 hours. The peptide concentration of 0.13 mM was determined by the tryptophan 
absorbance at 280 nm with an extinction coefficient of 5560 M
-1
 cm
-1
. Then the insertion 
of AcWL5 was confirmed by fluorescence using a Cary Eclipse fluorometer (Varian, Palo 
Alto, CA). A shift in the tryptophan fluorescence maximum from 345 nm in aqueous 
solution to 335 nm in lipid environment is expected.
90
 Poly-L-lysine was dissolved in 10 
mM phosphate buffer, pH 7.00, for a final concentration of 24 M. The pH was then 
raised to 11.40 using NaOH (Fisher Scientific, Pittsburgh, PA). The poly-L-lysine 
solution was then heated to 55 °C to produce β-sheet structure.   
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Deep Ultraviolet Resonance Raman Spectroscopy. 
The dUVRR system and those similar have been described elsewhere.
63,91
 An 
excitation wavelength of 197 nm was generated from the fourth harmonic of a 
Ti:sapphire laser pumped by a Nd:YLF laser system (Coherent Inc., Santa Clara, CA).  
Samples were held in a custom-made water-jacketed reservoir (Mid Rivers Glassblowing, 
St. Charles, MO) under nitrogen gas and circulated through a pair of nitinol wires by a 
Minipuls2 peristaltic pump (Gilson Inc., Middleton, WI) to generate a thin film of 
sample. The laser power at the sample was kept at less than 500 μW to prevent 
photodegradation. The Raman signal was collected by a Symphony CCD camera (Horiba 
Jobin Yvon Inc., Edison, NJ) with a chip size of 2048 × 512. A bin of 4 was applied in 
the horizontal direction for a final resolution of approximately 2.4 cm
-1
. Each spectrum 
was collected for 6 hours and exported using Synergy software (Horiba Jobin Yvon Inc., 
Edison, NJ). A small aliquot of 1 M sodium perchlorate solution was added to each 
sample for a final concentration of 50 mM as an internal intensity standard. All spectra 
were calibrated using a standard cyclohexane spectrum. 
 
Circular Dichroism Spectroscopy.  
All samples used for dUVRR analysis were additionally measured for their 
corresponding CD spectra. An AVIV 62DS circular dichroism (Aviv Biomedical Inc., 
Lakewood Township, NJ) spectrometer and a quartz cell with 1 mm optical path length 
(Hellma USA, Plainview, NY) were used to collect CD spectra. All spectra were 
collected between 190-250 nm with a resolution of 0.1 nm at room temperature. Every 
  
 
39 
 
sample was measured 5 times with a scan speed of 1 nm/5 s. Corresponding background 
spectra were collected in the same manner and subtracted from sample spectra.  
 
Data Analysis.  
All spectra were analyzed in the Matlab (Mathworks, Natick, MA) environment. 
Mean residue molar ellipticity [θMRE] was calculated as previously described63 and the 
spectra were fit with Gaussian bands. All dUVRR data were preprocessed using a custom 
cosmic spike removal tool, and buffer contributions were removed from averaged and 
baseline corrected spectra according to methods described elsewhere.
92
  
 
RESULTS 
A(25-40) contains the hydrophobic region of full length A(1-40), which is part 
of the TM domain of APP. To determine if A(25-40) could form a stable structure in the 
presence of membrane mimicking environments, CD and dUVRR spectra were recorded 
in the presence of neutral DMPC and anionic DMPG liposomes.  
 
Environmental Dependence of A(25-40)'s Structure.  
Previous studies of the structure of A(25-40) in aqueous environments indicate 
that the peptide adopts a disordered structure.
82, 63
 The CD spectra of A(25-40) have a 
strong negative feature at 197 nm and a weak negative feature at 220 nm, indicative of a 
predominantly disordered structure with a small amount of -strand structure (Figure III. 
1). Similarly, the dUVRR spectrum of the aqueous peptide is also consistent with a 
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disordered structure, as revealed by amide I, S, and III bands at 1656, 1387, and 
1249/1300 cm
-1
, respectively (Figure III. 2).
93
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
41 
 
 
Figure III. 1. CD spectra of Aβ(25-40) in aqueous buffer ( ), DMPG ( ) and 
DMPC (  ). 
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Figure III. 2. DVRR spectra of Aβ(25-40) in aqueous buffer (top), DMPC (middle), and 
DMPG (bottom). 
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Although it is thought that interactions with the membrane surface will cause -
sheet and aggregate formation, less is known about the structural consequences arising 
from this equilibration. In the presence of neutrally charged lipid bilayers (DMPC), 
A(25-40) forms -sheet structure very quickly. Specifically, the CD spectrum of A(25-
40) in solution with DMPC liposomes has a positive feature at 193 nm and a negative 
feature at 213 nm, which is consistent with -sheet structure,94 whereas the dUVRR 
spectrum has  a narrow amide I band located at 1662 cm
-1
, an asymmetrical amide S 
feature at 1399 cm
-1
, and an amide III region that can be deconvoluted into two features 
at 1237 and 1290 cm
-1
. The first amide III feature, sometimes referred to as the amide 
III3 mode
95,96
 is dependent on the Ψ dihedral angle, and a Raman shift of 1237 cm-1  is 
most consistent with -sheet structure.  
Association of A(25-40) with negatively charged liposomes (DMPG) has a 
significantly different influence on the secondary structures adpoted by this hydrophobic 
peptide. In fact, the CD spectrum of A(25-40), with a positive feature at 193 nm and 
two negative features at 209 and 221 nm, is consistent with classical -helical structure. 
In contrast, the dUVRR spectrum of the sample contains an amide III band contribution 
at 1244 cm
-1
 and a significant amide S band at 1384 cm
-1
, in addition to contributions at 
the -helical correlated positions (1299 cm-1), suggesting that the peptide contains both 
helical and nonhelical structures (Figure III. 2).
97
 Interestingly, the amide I mode of 
A(25-40) in DMPG is stronger in intensity than the amide II band and is best fit with 
two peaks centered at 1648 and 1674 cm
-1
. The first component at 1648 cm
-1
 is consistent 
with dehydrated helical structure,
98,99
 whereas the second component is consistent with -
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sheet structure. Previous studies have shown that the intensity of the amide I mode in 
dUVRR spectra is an intrinsic marker for membrane association
85,86
 and the increase in 
its intensity has been attributed to desolvation of the peptide backbone in membrane 
environments. Therefore, some portion of the A(25-40) backbone is likely hidden from 
water by the membrane. 
Although the first amide I feature at 1648 cm
-1
 is characteristic of helical 
structure, the second feature at 1674 cm
-1
 is higher than would be expected for disordered 
structure, but might be attributable to -sheet structure. However, there have been only a 
limited number of dUVRR studies on -sheet structured membrane proteins100; therefore, 
to aid in assigning the second amide I feature, a simple hydrophobic peptide, AcWL5, 
reported previously to assemble into a transmembrane -sheet when exposed to a lipid 
bilayer environment,
100, 101
 was examined. DUVRR studies conducted on AcWL5 in the 
presence of DMPC liposomes confirm that AcWL5 is associated with the membrane, 
because of the similarly intense amide I mode versus that of the soluble -sheet 
structured poly-L-lysine at high pH and temperature (Figure III. 3). The amide I region of 
AcWL5 can be fit by a single narrow band centered at 1675 cm
-1
, which directly overlaps 
with the amide I band in the -sheet poly-L-lysine spectrum. Amide III (1245 cm-1) and 
amide S (1400 cm
-1
) band positions confirm that AcWL5 adopts -sheet structure and 
indicate that the intense amide I position at 1675 cm
-1
 in the dUVRR spectrum of A(25-
40) in DMPG is likely derived from -sheet structural content. 
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Figure III. 3. DUVRR spectra of AcWL5 (top, TM β-sheet structure) and poly-L-lysine 
(bottom, soluble β-sheet structure). 
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Dependence of A(25-40) Structure on Hydrophobic Thickness.  
Because A(25-40) adopts a mixture of helical and -sheet structures and because 
some portion of this peptide appears to be buried in the membrane interior when exposed 
to  anionic DMPG lipid bilayers, assessment of the influence of hydrophobic thickness on 
the lipid equilibrated peptide structure is necessary. CD and dUVRR spectra of A(25-
40) were collected in the presence of DLPG and DDPG, which have hydrophobic 
thicknesses of 19.0 and 16.5 Å, respectively. The CD spectrum of A(25-40) in DLPG, 
dominated by a single positive feature at 192 nm and two negative features at 205 and 
223 nm,  indicates that the peptide adopts a mixture of -helical and disordered structures 
(Figure III. 4).  The loss of intensity at 223 nm when comparing the CD spectrum of 
A(25-40) with DLPG versus DMPG suggests a decrease in the peptide's helical content 
when equilibrating with thinner  lipid bilayers. The corresponding dUVRR spectrum is 
consistent with an increase of nonhelical content (Figure III. 5) as the amide S mode 
(1388 cm
-1
) is stronger in the dUVRR spectrum of A(25-40) interacting with DLPG 
versus DMPG bilayers. Furthermore, the position of the lowest frequency band in the 
amide III region of A(25-40) with DLPG occurs at 1250 cm-1, which is characteristic of 
disordered structure while the second easily resolved feature in the amide III region at 
1300 cm
-1
 is more consistent with -helical structural content.  
Converse to other anionic lipids and similar to the neutral DMPC membrane 
interactions, the negative feature at 219 nm and the positive feature at 193 nm (Figure III. 
4) in the CD spectrum as well as the amide III, S and I bands at 1241 cm
-1
, 1400 cm
-1
 and 
1668 cm
-1
 in the dUVRR spectrum of A(25-40) with DDPG (Figure III. 5) suggest a 
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predominantly -sheet structured peptide. These findings suggest that the thickness of the 
bilayer will influence the equilibration of the peptide with and within the membrane.  
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Figure III. 4. CD spectra of Aβ (25-40) with DMPG ( ), DLPG ( ) and DDPG ( ). 
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Figure III. 5. DUVRR spectra of Aβ(25-40) with DMPG (top), DLPG (middle) and 
DDPG (bottom). 
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Structural Transition of A(25-40) in DLPG over Time.  
Because A(25-40) equilibrates with anionic membranes and undergoes a 
structural transition in the presence of a membrane environment,  the equilibration of the 
peptide's structure over time is of interest to understand how these membranes may or 
may not facilitate the formation of -sheet composed fibrillar aggregates. Given that the 
transition temperature of DMPG is near room temperature and that A(25-40) appears 
not to equilibrate with or into DDPG lipid bilayers,  the CD spectrum of A(25-40) in 
DLPG liposomes, containing a mixture of  -helical and disordered structure, was 
monitored over time. Within the first 48 hours of incubation at room temperature, the 
positive feature at 193 nm increases, concurrent with a decrease of the negative feature at 
205 nm, indicating a loss of disordered structure (Figure III. 6). However, -sheet 
structure does not appear to contribute significantly to the CD spectrum until after 72 
hours of incubation. After 96 hours of incubation, the peptide contains a significant 
amount of -sheet structure as shown by a strong negative feature at 219 nm. The lack of 
an isosbestic point indicates that this process is not a two-state transition.  
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Figure III. 6. CD spectra of Aβ (25-40) with DLPG incubated over 96 hours at RT. 
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Structural Transition of A(1-40) in DLPG over Time.  
A(25-40) contains only the hydrophobic portion of the full length peptide, A(1-
40). Previous studies have shown that the full length peptide also interacts with 
membranes.
102
 However, whether the hydrophobic region will interact in a similar 
manner with anionic membranes when a significant water soluble portion is also present 
remains to be tested.  
Both CD and dUVRR spectra of A(1-42) in aqueous solution have been reported 
previously
82
 and should be similar to A(1-40) in its monomeric form.63,82,84  In the 
presence of DLPG liposomes, two minima located at 207 and 222 nm in the CD spectra 
indicate that A(1-40) also adopts a mixture of disordered and helical structures (Figure 
III. 7), which is similar to A(25-40).  To estimate the conformational changes in A(1-
40) over time better, CD spectra were fit using CD spectra derived from poly-L-lysine in 
its -helical, -sheet and disordered conformations.103 Three replicates of A(1-40) in 
DLPG spectra were analyzed in this manner (Figure III. 7 inset). These analyses suggest 
that the peptide gradually loses disordered character, in favor of a small amount of -
sheet structure after 48 hours of incubation at room temperature (Figure III. 7 
intermediate). Longer incubation times result in an overall loss of helical structure in 
favor of -sheet and disordered structure based on the fitted spectra. In each case, the 
final conformational ensemble is variable; therefore, ranges are given in the inset table 
(Figure III. 7) and the mean for each is reported (Table III. 1). The spectrum after 9 days 
of incubation shows that the minimum at 205 nm has shifted to 202 nm. The maximum at 
193 nm is also less intense, consistent with an increase in disordered structure. A 
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decrease in the intensity of the minimum at 222 nm is consistent with a loss of helical 
structure. 
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Table III. 1. Secondary structure estimation from CD spectra of Aβ(25-40) with 
liposomes and Aβ(1-40) with DLPG at three different stages. 
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Figure III. 7. Initial (blue), intermediate (red) and final (green) CD spectra of Aβ(1-40) 
with DLPG with simulations (dashed lines and inset table). 
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The dUVRR spectrum of A(1-40) prior to lipid addition is consistent with the 
peptide having a disordered conformation, as evidenced by the amide I (1669 cm
-1
), II 
(1557 cm
-1
), S (1393 cm
-1
) and III (1252 and 1297 cm
-1
) band positions (Figure III. 8 
aqueous). The bands at 1211 and 1608 cm
-1
 are derived from both the phenylalanine and 
tyrosine residues, which are absent in A(25-40). Phenylalanine also has a strong band 
located at 1002 cm
-1
 (not shown in the figure). Overall, the intensity of the aromatic 
modes increases upon transition from an aqueous to a lipid environment. The initial 
spectrum of A(1-40) interacting with DLPG liposomes (Figure III. 8 initial) shows that 
some portion of the full length A peptide has characteristics consistent with burial of the 
peptide backbone in the membrane, as indicated by the enhanced amide I band at 1663 
cm
-1
 and increased intensity of the aromatic modes (Figure III. 8 top difference 
spectrum). Increases in the amide mode intensities could be attributed to an -helical to 
-sheet or disordered conformational transition or, conversely, to a disordered to -sheet 
conformational transition. The final dUVRR spectrum of A(1-40) after 9 days of 
incubation in DLPG shows a loss of intensity at 1330 cm
-1
, consistent with a loss of -
helical structure. An increase in the intensity of the amide III band at 1240 cm
-1
, along 
with an increase in the amide S intensity, is also consistent with an increase in -sheet 
structure, indicating the latter pathway is the most likely. Table III. 2 summarizes the 
fitted amide mode positions for both A(25-40) and A(1-40).  
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Figure III. 8. DUVRR spectra of Aβ(1-40) in water (black) and initial (blue), intermediate 
(red) and final (green) with DLPG. The dotted lines are difference spectra of initial-water 
(blue dots), intermediate-initial (red dots), final-intermediate (green dots) and final-water 
(yellow dots). 
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Table III. 2. Summary of dUVRR positions of A(25-40) and A(1-40) with various 
liposomes. 
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DISCUSSION 
Previous studies have shown that the dramatically enhanced amide I band is a 
unique marker for desolvation of the peptide backbone, which can result from cross -
sheet core formation in amyloid fibrils or can be driven by the insertion of the peptide 
into a lipid environment.
85,86
 Because the amide I band intensity increases with the 
introduction of anionic lipids, but is not directly correlated with -sheet formation, some 
portion of the A(25-40) is likely buried in the anionic bilayer. Although the initial CD 
spectrum of A(25-40) in DMPG indicates the existence of a large percentage of -helix 
initially, the dUVRR spectrum of the same sample provides more detailed information. A 
typical -helical dUVRR spectrum should have three features within the amide III region: 
1276, 1293 and 1339 cm
-1
. A pure -helix should also lack an amide S feature, as this 
mode is disallowed in non-helical conformations.
104
 The spectrum of A(25-40) in 
DMPG has a relatively strong amide S feature and the amide III 1244 cm
-1
 feature is 
likely derived from non-helical secondary structure. These results are not surprising 
because the lysine residue near the N-terminus of the A(25-40) peptide provides a 
significant barrier to the full insertion of the peptide into the bilayer environment.  
Because the equilibration of A(25-40) is heavily influenced by bilayer thickness, 
hydrophobic mismatch is a potential cause of the structural complexity of A(25-40) in a 
lipid environment. Hydrophobic mismatch, when the protein structure is longer or shorter 
than the length of the lipid bilayer, may cause structural instability of TM peptides. The 
hydrophobic thickness of DMPG is estimated to be 23.5 Å. Assuming that all 29-40 
residues are embedded in the membrane and folded into a helical conformation, the 
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length of the helix would only be 18.0 Å, leading to hydrophobic mismatch. To fit the 
DMPG liposome, A(25-40) may form extended helices so that the peptide can span the 
bilayer, which is consistent with the lack of the characteristic 1300 and 1330 cm
-1
 
features in the amide III affiliated spectral region. Membrane thinning may also occur 
near the peptide because of lipid rearrangements, leading to the mixed secondary 
structure described earlier. DLPG has a hydrophobic thickness of 19.0 Å, which best fits 
the hydrophobic portion of the peptide but leaves the N-terminal residues outside the 
hydrophobic interior, resulting in the disordered structure identified by both CD and 
UVRR. The DDPG liposomes provide the thinnest hydrophobic region at 16.5 Å, while 
also having the most extreme curvature of any of the liposomes. Thus, it is plausible that 
DDPG cannot accommodate the peptide and that the hydrophobic portion of the peptide 
becomes exposed to the aqueous environment  and folds into -sheet structure. 
Full length A(1-40) is much more amphiphilic than the smaller A(25-40) 
peptide fragment, as it contains significant  hydrophobic and hydrophilic regions. On the 
basis of the initial, intermediate, and final CD and dUVRR spectra of A(1-40), a model 
of the structural transition of the peptide is proposed  (Figure III. 9). The initial stage 
contains a liposome embedded -helix formed by the C-terminus of A(1-40), whereas 
the N-terminus remains disordered and is exposed to the aqueous environment. The 
ordering parameters associated with the interactions of the peptide with the anionic lipid 
bilayer surface drive the transition to more folded structures,
105
 which, in this case, is -
sheet structure at the N-terminus, whereas the C-terminal -helix remains relatively 
stable initially. Lastly, as the stability of the -sheet structure takes hold, the -helix, 
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presumably held together by lateral forces of the membrane acyl chains,  is disrupted and 
begins to unfold and come out of the membrane. 
It is enticing to hypothesize that this in vitro derived scenario may mimic the 
process by which the newly cleaved A peptide emerges from the lipid bilayer. If this is 
in fact the case, then this would represent the first experimentally derived model for how 
A-sheet formation may occur initially.  
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Figure III. 9. Model of Aβ (1-40) interacting with DLPG liposomes via three stages: 
initial (blue), intermediate (red), and final (green). 
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Chapter IV  
Modeling Peptide Secondary Structure Stability in Membrane 
Environment by dUVRR 
 
ABSTRACT 
Transmembrane (TM) proteins perform a wide array of biological functions. 
Thus, their structural characterization draws great research interest. However, their 
relatively large sizes and the native lipid environment limit the application of traditional 
high resolution NMR and X-ray crystallography methodologies. DUVRR spectroscopy 
offers an alternative approach to reveal lipid solvated protein secondary structures as well 
as a potential solution to monitor the dynamics of TM proteins. To better understand how 
membrane characteristics affect the structural stability of TM proteins, a series of model 
peptides, poly-(LA)x, were designed to establish the relationship between the adopted 
structure and the spectral response. It is found that when associated with proper 
hydrophobic thicknesses, the model poly-(LA)x peptides show a dominant α-helical 
structure, while unsuitable bilayer thickness or peptide sizes lead to the increase of non-
helical structure. Moreover, the amide I intensity appears to be related to the solvation 
extent of a given peptide and reaches its minimum when the peptide is thoroughly buried 
within the lipid bilayer.  
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INTRODUCTION 
The interactions between proteins and biological membranes play an important 
role in many aspects of biochemistry and the structures of transmembrane (TM) proteins 
often change in response to external stimuli, enabling them to perform their innate 
function, including ion transport,
106
 chemical signaling
107,108
 and disease 
development.
2,109
 Although TM proteins are well known to adopt α-helial and β-barrel 
structures in their native environments,
110
 the relative insolubility and large size has 
limited the progress in simultaneously monitoring lipid association and structural 
characterization of TM proteins. Although there are over 84,000 available protein 
structures in the RCSB protein data bank nowadays,
111
 only very limited unique 
membrane structures are solved, compared to their soluble counterparts.
112
 To better 
understand protein structures in the membrane environment, previous research focused 
on NMR and X-ray crystallography studies of model peptides.
113,114
 A series of alanine 
and leucine rich peptides, KALP/WALP, were previously designed to not only 
demonstrate the inserted α-helical structure but also to determine the anchoring properties 
of lysine and tryptophan.
115
 However, traditional methodologies have been limited to 
analysis of the conformational changes of small membrane proteins and relatively slow 
dynamic motions. As a result, vibrational spectroscopies, such as infrared (IR), circular 
dichroism (CD) and Raman spectroscopies, have been relied upon for structural 
determination.
116,117
 
Recent deep UV resonance Raman (dUVRR) studies of lipid versus water 
solvated proteins reveals that the lipid solvated amide backbone has an altered spectral 
response, particularly in the amide I region.
85,86
 The intensity of the amide I mode in 
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dUVRR spectra appears to be an intrinsic marker for membrane association. The 
spontaneous insertion of short hydrophobic peptides into anionic lipid bilayers could be 
monitored by this phenomenon and the secondary structures of the peptides appear to be 
dependent on the bilayer thicknesses. 
 
EXPERIMENTAL PROCEDURES 
A series of poly-(LA)x peptides was purchased from Pi Proteomics, LLC 
(Huntsville, AL) with a purity of >95% and no further purification was carried out, and 
the sequences are summarized in Table IV. 1. Each peptide was dissolved in 1,1,1,1,3,3,3-
hexafluoro-2-proponal (HFIP), distributed into a number of test tubes, rapidly dried by 
argon and then sealed and stored at -20 °C for future use. Phosphate buffer was prepared 
using monobasic and dibasic sodium phosphate (Fisher Scientific, Pittsburgh, PA). 
Sodium chloride (Sigma, St. Louis, MO) was added on demand for proper ionic strength. 
Buffers were made from ultra pure water freshly prepared by a Barnstead Diamond 
system (Barnstead International, Dubuque, IA). DMPG, DLPG, DDPG and DOcPG 
powder were obtained from Avanti Polar Lipids (Alabaster, AL). DMPG was dissolved in 
a mixture of chloroform (Fisher Scientific, Pittsburgh, PA)/methanol (Fisher Scientific, 
Pittsburgh, PA)/water (65:35:8, v/v/v). DLPG, DDPG and DOcPG were dissolved in 
extra dry chloroform (Acros Organics, Geel, Belgium). Pre-dissolved lipids were then 
transferred into test tubes, dried by argon gas and the trace of solvent was removed under 
vacuum overnight. The lipids were then re-suspended in 20 mM phosphate buffer (pH 
7.4) with 5 mM NaCl, sonicated for 1 hour at 50 °C and uniform liposomes were then 
produced by extrusion through a 100 nm pore polycarbonate membrane LiposoFast 
  
 
66 
 
system (Avestin Inc., Ottawa, Canada). The concentration was then estimated by a 
Rouser assay and the size distribution of the vesicles was determined by a Dynapro-
MSTC dynamic light scattering (DLS) instrument (Protein Solution Inc., Somerest, NJ). 
Perchloric acid, ammonium molybdate (Fisher Scientific) and ascorbic acid (Sigma, St. 
Louis, MO) were also used in the phosphate assays to determine the concentration of the 
liposome solutions. Liposome solutions were then diluted and used to dissolve poly 
(LA)x peptide at a 1:100 peptide:liposome ratio and these solutions were left at room 
temperature overnight. The solutions were then spun by a Sorvall WX 80 ultracentrifuge 
(Thermo Scientific, Hudson, NH) at 35000 rpm for an hour and a half. The supernatant 
was removed and the pellets were re-suspended in buffer and the concentration was 
finally determined by UV-Vis at 280 nm. Fluorescence spectra of the samples were 
collected using a Cary Eclipse fluorescence spectrometer (Varian, Palo Alto, CA), using a 
3 mm path length quartz cell (Hellma USA, Plainview, NY). The fluorescence spectrum 
of each sample was measured using an excitation wavelength of 280 nm with a slit width 
of 5 nm and the emission spectrum was collected between 300 and 450 nm with a slit  
width of 5 nm. A tryptophan fluorescence maximum shift from 345 nm to 335 nm was 
expected, indicating that the peptide was in a lipid environment. 
 
 
 
 
 
 
  
 
67 
 
 
Table IV. 1. Summary of Poly-(LA)x sequences and their TM sizes. 
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Circular Dichroism Spectroscopy. 
An AVIV 62DS circular dichroism (Aviv Biomedical Inc., Lakewood Township, 
NJ) spectrometer with a quartz cell with a 1 mm optical path length (Hellma USA, 
Plainview, NY) was used to collect CD spectra. Every sample was measured between 
190-250 nm for secondary structure with a resolution of 0.1 nm at room temperature. A 
scan speed of 1 nm/5 s was applied, while 5 replicates were collected for the averaged 
spectrum. Corresponding background spectra were collected in the same manner and then 
subtracted from the raw data. 
 
Deep Ultraviolet Resonance Raman Spectroscopy.  
The dUVRR system has been described elsewhere.
63
 Briefly, a Nd:YLF laser 
system (Coherent Inc.) was used to generate a tunable Ti:Sapphire laser and an excitation 
wavelength (λex) of 197 nm was generated. Samples were held in a custom-made water-
jacketed reservoir (Mid Rivers Glassblowing) under nitrogen gas and circulated through a 
pair of nitinol wires by a Minipuls2 peristaltic pump (Gilson Inc.) to generate a thin film 
of sample. An isotemp 3016D circulating water bath (Fisher Scientific, Pittsburgh, PA) 
was used to stabilize the sample temperature. The laser power at the sample was kept at 
less than 500 μW to prevent photodegradation and a 135 back scattering geometry was 
applied to collect the Raman spectra. The Raman signal was collected by a Symphony 
CCD camera (Horiba Jobin Yvon Inc.) with a chip size of 2048 × 512. A bin of 4 was 
applied in the horizontal direction for a final resolution of approximately 2.4 cm
-1
. Each 
spectrum was collected for 6 hours and exported by the Synergy software (Horiba Jobin 
Yvon Inc.). Sodium perchlorate (50 mM) was applied as an internal intensity standard to 
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normalize all the dUVRR spectra while the Raman shifts were calibrated using a standard 
cyclohexane spectrum.  
 
Data Analysis 
All spectra were analyzed in the Matlab (Mathworks) environment. Mean residue 
molar ellipticity [θMRE] was calculated as previously described and the spectra were fitted 
with Gaussian bands. All dUVRR data were preprocessed using a custom cosmic spike 
removal tool and buffer contributions were removed from averaged and baseline 
corrected spectra according to methods described elsewhere 
82
. Amide I regions of the 
Raman spectra were fit by a mixture of Gaussian and Lorentzian bands and peak area was 
estimated by integrating the peak fits. 
 
RESULTS 
Peptides with leucine-alanine repeats have a high propensity to fold into α-helical 
structures and will spontaneously insert into model membranes. Lysine (K) residues at 
each end of the sequence increase the solubility of the peptides and anchor the peptide to 
the lipid-bilayer by interacting with negatively charged lipid head groups. A tryptophan 
residue at the center of the polypeptide can be used to monitor insertion.
115
 Tryptophan 
fluorescence is characteristically blue-shifted in hydrophobic lipid environments. Circular 
dichroism (CD) was used to monitor folding initially (data not shown). To further test 
what role hydrophobic mismatch is playing in determining the final structure, dUVRR 
spectra of a series of poly-(LA)x peptides in 5 mM DMPG (14:0), DLPG (12:0), DDPG 
(10:0) and DOcPG (8:0) were collected (Figure IV. 1).  
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Dependence of the Secondary Structure of Poly-(LA)x on Hydrophobic 
Thicknesses 
The hydrophobic thickness decreases approximately 10.5 Å upon going from 
DMPG to DOcPG (Figure IV. 1 A). Poly-(LA)5 peptide appears to adopt a mixture of α-
helical and β-sheet structures in liposomes with smaller hydrophobic thicknesses. This is 
evidenced by the strengthening of the two α-helices correlated amide III bands at 1300 
and 1339 cm
-1
. At the same time, the band at 1247 cm
-1 
decreases in intensity along with 
increasing hydrophobic thickness. Although the amide III region varies as the thickness 
changes, the amide S region stays almost intact with a band at 1402 cm
-1
. Decreasing 
content of non-helical structure should decrease the amide S intensity, although it is not 
seen in the results. The amide II region contains one peak centered at 1554 cm
-1
, while 
the amide I region was deconvoluted into three features located at 1608, 1665 and 1700 
cm
-1
.  
Poly-(LA)6 shows different results from poly-(LA)5, although it contains only two 
more residues (Figure IV. 1 B). DUVRR of poly-(LA)6 indicates that the peptide adopts 
predominantly α-helical structure. The spectra of poly-(LA)6 in DLPG, DDPG and 
DOcPG are very similar in the amide III region, with three features centered at 1260, 
1301 and 1337 cm
-1, respectively, indicating the existence of α-helix. However, there is 
an extra 1249 cm
-1
 amide III feature when poly-(LA)6 interacts with DMPG. In addition, 
the amide S peak located at 1392 cm
-1
 suggests there is non-helical structure present as 
well in the DLPG and DMPG samples. Moreover, the amide I feature shifts gradually 
from 1654 cm
-1
 in the DOcPG spectra to 1667 cm
-1
 in the DMPG spectra, which also 
indicates the increasing content of β-sheet structure.  
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The dUVRR spectra of poly-(LA)7 and poly-(LA)8 appear similar, with three 
amide III band positions characteristic of α-helix structure (1275, 1305, and 1335 cm-1, 
respectively, Figure IV. 1 C and D). In addition, the absence of an amide S band in poly-
(LA)7 or poly-(LA)8 under various conditions also confirms that the peptides adopt an α-
helical conformation. However, the amide I position in poly-(LA)7 gradually shifts from 
1650 to 1656 cm
-1
 with the increase in hydrophobic thickness. Similar behavior is also 
observed with poly-(LA)8. These results indicate that hydrophobic mismatching may play 
a significant role in the stability of the peptides' adopted structures, as the peptides 
potentially form extend helical or β-sheet structures. 
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Figure IV. 1. DUVRR spectra of poly-(LA)x with various liposomes.  
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The Amide I Intensity Correlates with the TM Length of Peptides   
Previous studies indicate that the amide I intensity could be increased 
dramatically with peptide-membrane interaction, although there is as yet no evidence to 
correlate the amide I intensity to the number of transmembrane residues. To investigate 
the relationship between the amide I region and the size of TM fragment, DDPG and 
DLPG were chosen to accommodate the poly-(LA)x peptides because DMPG has a 
transition temperature near room temperature and DOcPG does not provide enough 
hydrophobic thickness. Figures IV. 2 and 3 summarize the spectral response of the poly-
(LA)x in DDPG and DLPG, respectively. All the asymmetrical amide I regions are fit 
with three bands to calculate the total peak area, centered at 1620, 1655 and 1690 cm
-1
, 
respectively (Figure IV. 4). Compare to the relatively stable peak area at 1620 and 1690 
cm
-1
, the area of the major one around 1655 cm
-1
 decrease as a function of increasing TM 
length, while the positions downshift at the same time. The exponential regression of the 
amide I intensities vs. number of TM residues is demonstrated in Figure IV. 5. The 
regression results clearly show that in the presence of DDPG, the amide I intensit ies 
around 1650 cm
-1
 decrease with increase in the TM fragment length. Considering that the 
lysine residues on each end of the peptide will anchor the peptide through the membrane, 
the shortest peptide needs to be stretched to a more extend state to be buried in the 
membrane, which causes a decrease in helicity. Similar results can be found in the 
presence of DLPG, with less change regarding the other two components. 
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Figure IV. 2. DUVRR spectra of poly-(LA)x with DDPG liposomes. Peptides show a 
tendency to form α-helical structure with increasing TM length. 
 
 
 
 
 
 
 
 
 
 
 
  
 
75 
 
 
Figure IV. 3. DUVRR spectra of poly-(LA)x with DLPG liposomes. Peptides show a 
tendency to form α-helical structure with increasing TM length. 
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Figure IV. 4. Three component could be fit for the amide I area, and the overall intensity 
decreases as the number of TM residues increases. 
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Figure IV. 5. Amide I component at 1655 cm
-1
 decreases as the number of TM residues 
increases, indicated by exponential fitting. 
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Peptide Structural Preference Against Mixed Lipids  
Discrete lipid domains are expected to form when the difference in hydrophobic 
thickness of the bilayer is at least 7 Å. The CD spectrum of poly-(LA)5 with 100% DLPG 
indicates that the peptide adopts a dominant β-sheet structure (Figure IV. 5, blue), 
evidenced by a positive feature located at 197 nm, and a negative feature located at 217 
nm. However, the poly-(LA)5 may contain α-helical conformation as well, which is 
indicated by a slight negative component at 208 nm.  Meanwhile, when interacting with 
DOcPG liposomes, poly-(LA)5 adopts a dominant α-helical structure (Figure IV. 5, 
brown), evidenced by two negative features locate at 208 and 222 nm, respectively, and a  
positive feature at 193 nm. The comparison of the simulated and experimental CD spectra 
of poly-(LA)5 in mixed DOcPG/DLPG liposomes shows that the peptide is less helical 
than expected with 50% DOcPG (Figure IV. 5, green) and more helical than expected 
with 75% DOcPG (Figure IV. 5, red). These data suggest that the β-sheet conformation 
may be more stable than the α-helical conformation. 
DUVRR spectra confirm that the peptide is more stable as a β-sheet conformation 
(Figure IV. 6). Poly(LA)5 in 75% DLPG (75:25 DLPG:DOcPG) is similar to the 
spectrum of the peptide in 100% DLPG (Figure IV. 6 magenta and blue), consistent with 
the CD results. Specifically, the amide III region contains both 1246 and 1400 cm
-1
 
features, which are characteristic of β-sheet structures. The amide III region also contains 
weak contributions at 1299 and 1341 cm
-1
, which are associated with α-helical structure. 
However, the amide I region could be deconvoluted into one major component located at 
1666 cm
-1
, which is related to β-sheet structure. Furthermore, the dUVRR spectrum of 
Poly-(LA)5 in liposomes with 75% DOcPG (25:75 DLPG:DOcPG) is similar to the 
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spectrum of the peptide in 100% DOcPG (Figure IV. 6 red and brown). Compared to the 
75% DLPG (75:25 DLPG:DOcPG) spectrum, the increased 1299 cm
-1
 band  in the amide 
III region as well as the decreased feature at 1246 cm
-1
 indicates the peptide adopts a 
more α-helical conformation with decreasing DLPG percentages. The amide S band 
located at 1400 cm
-1
 also diminished dramatically, consistent with an increasing α-helical 
content. The dUVRR spectrum of Poly-(LA)5 in liposomes composed of a 50:50 mixture 
of DLPG and DOcPG appears to be more helical than in the 75:25 mixture (Figure IV. 6 
green), by showing an increased contribution at 1299 cm
-1
 and a slightly reduced 1400 
cm
-1
 amide S contribution. Overall, all the UVRR spectra of poly-(LA)5 in mixed 
liposomes contain a amide I feature located at 1666 cm
-1
, indicating the peptides may 
prefer to fold into β-sheet structure, although the slightly increased amide II/amide I 
intensity ratio may lead to the conclusion that the peptide folds into a more dehydrated 
state.   
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Figure IV.6. Simulated and experimental CD spectra of poly-(LA)5 in mixed 
DOcPG/DLPG liposomes. 
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Figure IV.7.  DUVRR spectra of poly-(LA)5 in mixed DOcPG/DLPG liposomes (75% 
DLPG in magenta, 50% DLPG in DLPG in green, and 25% DLPG in red). 
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DISCUSSION 
Hydrophobic mismatch potentially causes the structural equilibration of poly-
(LA)x in the various bilayer thicknesses
114
; thus it is important to gather information 
about both the TM lengths of the model peptides and the hydrophobic thicknesses of the 
bilayers. The hydrophobic thickness of DMPG is estimated to be 23.5 Å, and it will 
decrease approximately 4.5 Å in the DLPG liposomes for a total of 19.0 Å. DDPG and 
DOcPG could be estimated in a similar manner for a result of 14.5 and 10 Å, respectively. 
Given the fact that the poly-(LA)x peptides contains 12-18 TM residues, the peptides 
would occupy 18, 21, 24, and 27 Å of a TM -helix, respectively. It is logical to claim 
that when the hydrophobic thickness exceeds the length of the TM region of the peptide, 
the peptide will form an extended structure to be accommodated in the membrane, 
leading to the presence of β-sheet structure. On the contrary, if the hydrophobic thickness 
is less than the TM length, -helical structure is preferred. It is possible that the lipids 
will migrate to bury the TM peptide, or the peptide will form a compressed -helical 
structure to fit the membrane. Protein aggregation is unlikely to happen, because the 
position and intensity of the amide I regions indicate the peptides are still associated with 
the membrane. However, it is not clear whether the helices are inserted perpendicular to 
the membrane based on the dUVRR results. In ordered to determine the orientation of the 
membrane-associated poly-(LA)x, further investigation will be needed.  
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Chapter V  
Summary and Future Directions 
 
As the most common type of dementia, Alzheimer’s disease is devastating in the 
prospective elderly community.
118
 In order to develop effective therapeutic strategies for 
AD, detailed information regarding how Aβ is generated, stabilized and aggregated into 
fibrils has garnered worldwide attention yet is still in demand. Preventing, reversing or 
halting the aggregation of Aβ with polyphenolic compounds  has been proven to be 
effective
22,119-122
 although there is still the lack of a mechanism behind the anti-
amyloidogenic characteristics. 
In this work, the intrinsic aggregation driving force of Aβ(25-40) as well as 
potential myricetin-Aβ binding pathways is examined by G37A and I32A mutations 
through various spectroscopic methods. It is found that: 
1. ThT assays suggest that the I32A mutation significantly reduces the extent and 
rate of the peptide aggregation, indicating that hydrophobic interactions play a 
large role in the aggregation of Aβ(25-40). 
2. CD spectra indicate that the secondary structures of the mutants are similar to one 
another but may have slightly more disordered content versus the native peptide.  
3. The similar UVRR spectra of Aβ(25-40) and its mutants suggest that the 
modifications do not affect the secondary structure dramatically, but a slight 
difference in the amide I region indicates a variation in the oligomeric distribution. 
4. Size exclusion chromatography showed that the size distribution of the I32A and 
G37A oligomers is significantly different from the Aβ(25-40) oligomers. 
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 The generation of Aβ involves the peptide leaving its native membrane 
environment. Thus, understanding how membrane characteristics affect the behavior of 
A would lead to potential strategies to prevent the neurotoxicity of A and ultimately 
the development of AD. Combined application of dUVRR and CD indicates that:  
1. A(25-40) and A(1-40) spontaneously fold upon association with anionic lipid 
bilayers.  
2. The structure of the membrane-associated A(25-40) peptide depends on both the 
hydrophobic thickness of the bilayer and duration of incubation.  
3. A(1-40) initially adopts a mixture of disordered and helical structures, which 
slowly convert to disease associated -sheet structures over several days.  
4. A model is proposed to describe the mechanism of escape of A(1-40) from the 
membrane surfaces following its formation by cleavage of APP within the 
membrane. 
 Previous studies have already shown the cleavage process of APP to generate A 
in membrane, but less is known regarding the stability of membrane-associated A and 
its structural changes before leaving the membrane environment. With the fact that A 
demonstrates structural complexity in membrane, a series of TM α-helical model peptides, 
poly-(LA)x, were employed to investigate the parameters that affect the adopted structure 
and the spectroscopic results reveal: 
1. The UVRR studies indicate that hydrophobic mismatching may play a significant 
role in the stability of the peptides’ adopted structure. 
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2. TM secondary structures depend on both the TM length of peptides and the 
hydrophobic thicknesses. 
3. The peptide is less helical than expected with up to 50% DOcPG and more helical 
than expected with 75% DOcPG, which suggest that the β-sheet conformation 
may be more stable than the α-helical conformation in a thinner hydrophobic 
thicknesses. 
 In essence, dUVRR is a powerful technique to monitor protein secondary 
structure in various environments and to provide information about the protein and its 
surrounding environment. As of now, studies on how small molecules interact with the 
full length Aβ(1-40) and Aβ(1-42) are being carried out. At the same time, secondary 
structure breakers, like glycine and proline, are under investigation to develop the 
structural relationships between peptide sequence and TM helicity.   
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